Feiyang Luo
Chongqing, 400010, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Functional avidity enhancement of a T-cell receptor targeting the KRASG12D cancer neoantigen.
Journal: Cellular immunology
Published: April 01, 2025
A Novel Circular Delta-XBB15 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS-CoV-2 Variants in Mice.
Journal: Journal of medical virology
Published: August 05, 2024
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.
Journal: JCI insight
Published: April 05, 2023
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection.
Journal: Frontiers in medicine
Published: June 16, 2022
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery.
Journal: Signal transduction and targeted therapy
Published: March 09, 2022
Structures of Omicron spike complexes and implications for neutralizing antibody development.
Journal: Cell reports
Published: February 07, 2022
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.
Journal: Frontiers in immunology
Published: October 05, 2021
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy.
Journal: Frontiers in molecular biosciences
Published: August 10, 2021
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
Journal: Biochemical and biophysical research communications
Published: June 09, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.
Journal: Frontiers in immunology
Published: January 14, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026